BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20976576)

  • 1. Will sublingual immunotherapy become an approved treatment method in the United States?
    Cox L; Compalati E; Canonica W
    Curr Allergy Asthma Rep; 2011 Feb; 11(1):4-6. PubMed ID: 20976576
    [No Abstract]   [Full Text] [Related]  

  • 2. Perception and practice of sublingual immunotherapy among practicing allergists.
    Tucker MH; Tankersley MS;
    Ann Allergy Asthma Immunol; 2008 Oct; 101(4):419-25. PubMed ID: 18939732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sublingual immunotherapy and subcutaneous immunotherapy: issues in the United States.
    Greenberger PA; Ballow M; Casale TB; Platts-Mills TA; Sampson HA
    J Allergy Clin Immunol; 2007 Dec; 120(6):1466-8. PubMed ID: 17936891
    [No Abstract]   [Full Text] [Related]  

  • 4. Sublingual immunotherapy.
    Heinzerling L; Worm M; Bergmann KC; Zuberbier T
    J Dtsch Dermatol Ges; 2006 May; 4(5):428-33; quiz 434-5. PubMed ID: 16686612
    [No Abstract]   [Full Text] [Related]  

  • 5. 2006 American Academy of Allergy, Asthma & Immunology member immunotherapy practice patterns and concerns.
    Coifman RE; Cox LS;
    J Allergy Clin Immunol; 2007 Apr; 119(4):1012-3. PubMed ID: 17418663
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of allergen immunotherapy practice patterns in the United States and Europe.
    Cox L; Jacobsen L
    Ann Allergy Asthma Immunol; 2009 Dec; 103(6):451-59; quiz 459-61, 495. PubMed ID: 20084837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current standards and future directions in immunotherapy: perspectives on challenges and opportunities for the allergist.
    Bernstein DI; Blaiss MS; Cox LS; Finegold I; Lanier BQ; Nelson HS; Wallace DV
    Ann Allergy Asthma Immunol; 2011 Nov; 107(5):422-5. PubMed ID: 22018613
    [No Abstract]   [Full Text] [Related]  

  • 8. Sublingual immunotherapy.
    Esch RE
    Curr Opin Otolaryngol Head Neck Surg; 2008 Jun; 16(3):260-4. PubMed ID: 18475082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perception and practice of sublingual immunotherapy among practicing allergists in the United States: a follow-up survey.
    Sikora JM; Tankersley MS;
    Ann Allergy Asthma Immunol; 2013 Mar; 110(3):194-197.e4. PubMed ID: 23548531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The allergist and the intensivist: not such odd bedfellows.
    Pillay K; Fung SS; Cohn JR
    Ann Allergy Asthma Immunol; 2014 Feb; 112(2):94-6. PubMed ID: 24468246
    [No Abstract]   [Full Text] [Related]  

  • 11. Are "off-labels" legal?
    Price EC
    Mich Health Hosp; 1998; 34(6):20-1. PubMed ID: 10187136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific immunotherapy with allergen mixes: what is the evidence?
    Nelson HS
    Curr Opin Allergy Clin Immunol; 2009 Dec; 9(6):549-53. PubMed ID: 19745727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Turning a blind eye.
    Nat Med; 2008 Jan; 14(1):1. PubMed ID: 18180702
    [No Abstract]   [Full Text] [Related]  

  • 14. Sublingual immunotherapy: a comprehensive review.
    Cox LS; Larenas Linnemann D; Nolte H; Weldon D; Finegold I; Nelson HS
    J Allergy Clin Immunol; 2006 May; 117(5):1021-35. PubMed ID: 16675328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Off-label drugs: question your doctor.
    Consum Rep; 2007 Jun; 72(6):47. PubMed ID: 17632948
    [No Abstract]   [Full Text] [Related]  

  • 16. Should you let the FDA decide what drugs you pay for?
    Dutton G
    Bus Health; 1996 Oct; 14(10):65, 69-70, 73. PubMed ID: 10161492
    [No Abstract]   [Full Text] [Related]  

  • 17. Herbalism in Minnesota. What should physicians know?
    Plotnikoff GA; George J
    Minn Med; 1999 May; 82(5):12-26. PubMed ID: 10337136
    [No Abstract]   [Full Text] [Related]  

  • 18. Be wary of recommending off-label use of meds.
    Luttrull S
    Adv Nurse Pract; 2001 Feb; 9(2):18. PubMed ID: 12416047
    [No Abstract]   [Full Text] [Related]  

  • 19. Off-label pharmaceutical use: balancing information, risks, and benefits.
    Kozma CM
    Manag Care Interface; 2004 Jan; 17(1):29-30. PubMed ID: 15035597
    [No Abstract]   [Full Text] [Related]  

  • 20. Unapproved uses of approved drugs: the physician, the package insert, and the Food and Drug Administration: subject review. American Academy of Pediatrics Committee on Drugs.
    Pediatrics; 1996 Jul; 98(1):143-5. PubMed ID: 8668390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.